Here we are at the midpoint of 2016 already. Time to look back on the past six months—and some of the top stories of the year so far.
The following represent a cross-section of what Xconomy offers on a daily basis:... Read more »
VP of Research & Policy, Ewing Marion Kauffman Foundation
Founder and Managing Partner, Frazier Healthcare Ventures
Founding Director, Massachusetts Technology Transfer Center
Chairman, CEO, & Founder, Alexandria Real Estate Equities
Vice president, chief strategy and operating officer of the Texas Medical Center
Managing Director, D.E. Shaw and Co., L.P.
VP of Research and Special Initiatives, Google
Founder and Managing Director of DEV
|
Here we are at the midpoint of 2016 already. Time to look back on the past six months—and some of the top stories of the year so far.
The following represent a cross-section of what Xconomy offers on a daily basis:... Read more »
The word of the week was “moonshot,” as U.S. Vice President Joe Biden’s cancer initiative convened a summit in Washington, DC. At the gathering, Biden took verbal shots at scofflaw cancer researchers and at drug prices, while the FDA said... Read more »
Healthtech entrepreneur Parker Hinshaw and his wife Jean Balgrosky said they intended to take a step back when they founded Bootstrap Incubation near San Diego in the fall of 2012.
They wanted to combine Hinshaw’s experience in starting and growing health... Read more »
As part of a national cancer “moonshot” initiative led by Vice President Joe Biden, the FDA said Wednesday it would retool the way it evaluates cancer treatments and tests.
But to what end?
The goals of the FDA’s new Oncology Center... Read more »
Inside our bodies, our cells move around, communicate, form new tissue, and heal wounds with the help of proteins called integrins. But when disease occurs, integrins get the wrong cues and do damage—they might help tumors grow, or promote inflammation or... Read more »
Reflexion Health, a San Diego startup founded in 2012 at the nonprofit West Health Institute, is moving to commercialize Vera, its physical rehabilitation system based on Microsoft Kinect’s motion tracking technology.
After recently raising $18 million in Series B funding, the... Read more »
Modern Meadow, a New York-based company that has developed a method of turning living cells into materials used to make leather that mimics animal hide, has received a $40 million Series B funding to begin manufacturing and commercializing its leather products.... Read more »
A new wave of drugs has changed the way hepatitis C is treated. Regulus Therapeutics has not been part of that wave, but the company’s plans to join it took a big hit this afternoon.
La Jolla, CA-based Regulus (NASDAQ: RGLS... Read more »
It’s a week for the history books. The United Kingdom voted to leave the European Union last night, triggering worldwide financial fears and, perhaps, a breakup of the U.K. itself. Closer to home, Cleveland (pictured) celebrated LeBron James & the Cavaliers’... Read more »
Google Fiber plans to acquire Webpass in a deal that trims the ranks of independent Internet service providers—an industry already maligned for its lack of competition—but ultimately could boost consumer access to high-speed Internet.
San Francisco-based Webpass has spent the past... Read more »
San Diego’s cybersecurity workforce has grown by nearly 15 percent over the past two years, according to a study released today by the Cyber Center of Excellence, a nonprofit industry group created to boost cybersecurity jobs and technologies in the region.... Read more »
So far, the story of IBM Watson Health has been mostly about growth and potential. Today, it’s more about action.
The healthcare computing giant, now headquartered in Cambridge, MA, is unveiling a collaborative effort in medical imaging that includes partnerships... Read more »
Radicle, a new accelerator fund focused on agricultural ventures, is launching today with plans to seed and nurture the next generation of agtech companies addressing global farming problems.
The new accelerator will have locations in multiple states and around the world.... Read more »
Six San Diego business risk-takers have been inducted into the pantheon of EY Entrepreneurs of the Year, joining over 10,000 people around the world who have been honored over the last 30 years by the multinational professional services firm.
An independent... Read more »
Familiar biotech names—not necessarily familiar for the right reasons—made news this week in biotech. Data from a hematology conference stoked dreams of approval, though still on a far horizon, for a couple drug makers. Long anticipated, Walgreens officially cut ties with... Read more »
What does it take to build a startup in today’s market?
Put a half-dozen entry-level tech entrepreneurs together anywhere outside of the Bay Area, and it won’t take long before they start listing the local market deficiencies. In San Diego, the... Read more »
Startup Week San Diego, like a lot of other places that host similar events, has been billed as a weeklong celebration of entrepreneurship.
Seattle’s UP Global, now part of Techstars, oversees the operation of Startup Week and other programs for tech... Read more »
If you blinked, you probably missed something this week in biotech. The nation’s biggest annual cancer meeting took place in Chicago, while biotech’s trade group held its annual confab in San Francisco. In Boston, there were more twists for a closely... Read more »
After operating in the shadows for the past 11 years, a San Diego neural technology company founded by former NASA administrator Dan Goldin is stepping into the light to introduce two commercial products intended to advance the frontier of human-machine interaction.... Read more »
It was fitting this week that, in the lead-up to two of biomedicine’s biggest self-celebrations, we were served ample reminder of the industry’s expensive decisions gone wrong. This weekend, much of academia and industry involved in cancer will gather in Chicago... Read more »
After a painful restructuring earlier this year, Berkeley, CA-based 3D Robotics appears to be raising additional capital.
The high-profile drone startup, which raised $50 million in venture funding early last year in a Series C funding round led by San Diego-based... Read more »
BioMarin Pharmaceutical took a $680 million gamble when it bought Prosensa in 2014 for its experimental Duchenne muscular dystrophy treatment. Drisapersen (Kydrisa) had already failed a Phase 3 trial, but BioMarin bet it could dig through the data and win FDA... Read more »
Partner at New Enterprise Associates
Founder and Managing Partner, City Hill Ventures
CEO, Kura Oncology; Co-founder & CEO, Avidity NanoMedicines; Co-founder and CEO, Wellspring Biosciences
Chief of Genetics, UC San Diego School of Medicine
Head, Janssen Healthcare Innovation
Prof., Molecular Biology and Chemistry, Scripps Research Institute
Former President and CEO, Regulus Therapeutics
Professor, Gene Expression Laboratory, Salk Institute
Professor of Chemistry, Scripps Research Institute